Cormorant-Asset-Management-Lp

AI_NATIVE detailed information: This accession holds the following tickers:[
  "MRUS",
  "AXSM",
  "EWTX",
  "CNTA",
  "INSM",
  "NAMS",
  "ARQT",
  "ABVX",
  "RAPP",
  null,
  "STOK",
  "PHVS",
  "ALMS",
  "JANX",
  "BIOA",
  null,
  "TARS",
  null,
  "KALA",
  "KRRO",
  null,
  "OKUR",
  "GHRS",
  "SPRY",
  "RNA",
  "MBX",
  "PRAX",
  "PLRX",
  "RYTM",
  "MLTX",
  "ACLX",
  null,
  "ELVN",
  "EYPT",
  "BHVN",
  "PCVX",
  "BMEA",
  "BBIO",
  "CRGX",
  "CGON",
  "CRBP",
  "CRNX"
]

Filing Details

13F-HR • 2025-03-31

SEC FilingSEC DataHachi Filing

Report Date: 2025-03-31
Filing Date: 2025-05-15
Total Holdings: 42
Total Value: 1218119015
Accession Number: 0001583977-25-000005
Form Type: 13F-HR
CIK: cormorant-asset-management-lp
Manager Name: Cormorant-Asset-Management-Lp

Data Enrichment

88% identified

37 identified5 unidentified

Holdings

SEC FilingSEC DataHachi Filing

Manager:

42 positions • $1.2B total value

SEC FilingSEC DataHachi Filing

Manager:

Search and click to pin securities to the top

Page 2 of 3

Sort by:

CARGO Therapeutics, Inc.

CRGX|14179K101

Shares:3.4M

Value:$13.8M

% of Portfolio:1.1% ($13.8M/$1.2B)

Abivax S.A.

ABVX|00370M103

Shares:2.1M

Value:$13.3M

% of Portfolio:1.1% ($13.3M/$1.2B)

ALUMIS INC.

ALMS|022307102

Shares:2.1M

Value:$13.2M

% of Portfolio:1.1% ($13.2M/$1.2B)

Corbus Pharmaceuticals Holdings, Inc.

CRBP|21833P301

Shares:2.4M

Value:$12.6M

% of Portfolio:1.0% ($12.6M/$1.2B)

Avidity Biosciences, Inc.

RNA|05370A108

Shares:400.0K

Value:$11.8M

% of Portfolio:1.0% ($11.8M/$1.2B)

59267L107

Shares:400.0K

Value:$10.9M

% of Portfolio:0.9% ($10.9M/$1.2B)

29286M105

Shares:2.3M

Value:$10.4M

% of Portfolio:0.9% ($10.4M/$1.2B)

BioAge Labs, Inc.

BIOA|09077V100

Shares:2.6M

Value:$9.9M

% of Portfolio:0.8% ($9.9M/$1.2B)

RHYTHM PHARMACEUTICALS, INC.

RYTM|76243J105

Shares:150.0K

Value:$7.9M

% of Portfolio:0.7% ($7.9M/$1.2B)

OnKure Therapeutics, Inc.

OKUR|68277Q105

Shares:1.8M

Value:$7.9M

% of Portfolio:0.6% ($7.9M/$1.2B)

Biomea Fusion, Inc.

BMEA|09077A106

Shares:3.6M

Value:$7.6M

% of Portfolio:0.6% ($7.6M/$1.2B)

Korro Bio, Inc.

KRRO|500946108

Shares:380.3K

Value:$6.6M

% of Portfolio:0.5% ($6.6M/$1.2B)

Vaxcyte, Inc.

PCVX|92243G108

Shares:175.0K

Value:$6.6M

% of Portfolio:0.5% ($6.6M/$1.2B)

002942100

Shares:800.2K

Value:$6.0M

% of Portfolio:0.5% ($6.0M/$1.2B)

MBX Biosciences, Inc.

MBX|55287L101

Shares:700.0K

Value:$5.2M

% of Portfolio:0.4% ($5.2M/$1.2B)

NewAmsterdam Pharma Co N.V.

NAMS|N62509109

Shares:250.0K

Value:$5.1M

% of Portfolio:0.4% ($5.1M/$1.2B)

Enliven Therapeutics, Inc.

ELVN|29337E102

Shares:250.0K

Value:$4.9M

% of Portfolio:0.4% ($4.9M/$1.2B)

Janux Therapeutics, Inc.

JANX|47103J105

Shares:150.0K

Value:$4.0M

% of Portfolio:0.3% ($4.0M/$1.2B)

PLIANT THERAPEUTICS, INC.

PLRX|729139105

Shares:3.0M

Value:$4.0M

% of Portfolio:0.3% ($4.0M/$1.2B)

KALA BIO, Inc.

KALA|483119202

Shares:603.0K

Value:$3.5M

% of Portfolio:0.3% ($3.5M/$1.2B)

Instrument	Shares		Other Manager	Value	% of Portfolio
CARGO Therapeutics, Inc.(CRGXcusip14179K101)	3.4M	QoQ +185.92% (-2.2M) YoY +185.92% (-2.2M)	All Managers (Combined)	$13.8M	1.1% ($13.8M/$1.2B)	QoQ -19.29% (-$3.3M) YoY -47.86% (-$12.6M)
Abivax S.A.(ABVXcusip00370M103)	2.1M	QoQ 0.00% (-0) YoY 0.00% (-0)	All Managers (Combined)	$13.3M	1.1% ($13.3M/$1.2B)	QoQ -14.61% (-$2.3M) YoY -56.29% (-$17.1M)
ALUMIS INC.(ALMScusip022307102)	2.1M	QoQ 0.00% (-0) YoY NEW(+2.1M)	All Managers (Combined)	$13.2M	1.1% ($13.2M/$1.2B)	QoQ -21.88% (-$3.7M) YoY NEW(+$13.2M)
Corbus Pharmaceuticals Holdings, Inc.(CRBPcusip21833P301)	2.4M	QoQ 0.00% (-0) YoY +17.28% (-350.0K)	All Managers (Combined)	$12.6M	1.0% ($12.6M/$1.2B)	QoQ -55.00% (-$15.4M) YoY -84.12% (-$66.8M)
Avidity Biosciences, Inc.(RNAcusip05370A108)	400.0K	QoQ -61.90% (-650.0K) YoY NEW(+400.0K)	All Managers (Combined)	$11.8M	1.0% ($11.8M/$1.2B)	QoQ -61.32% (-$18.7M) YoY NEW(+$11.8M)
(cusip59267L107)✕	400.0K	QoQ NEW(+400.0K) YoY NEW(+400.0K)	All Managers (Combined)	$10.9M	0.9% ($10.9M/$1.2B)	QoQ NEW(+$10.9M) YoY NEW(+$10.9M)
(cusip29286M105)✕	2.3M	QoQ 0.00% (-0) YoY +132.35% (-1.3M)	All Managers (Combined)	$10.4M	0.9% ($10.4M/$1.2B)	QoQ -32.63% (-$5.0M) YoY -38.58% (-$6.5M)
BioAge Labs, Inc.(BIOAcusip09077V100)	2.6M	QoQ 0.00% (-0) YoY NEW(+2.6M)	All Managers (Combined)	$9.9M	0.8% ($9.9M/$1.2B)	QoQ -35.06% (-$5.3M) YoY NEW(+$9.9M)
RHYTHM PHARMACEUTICALS, INC.(RYTMcusip76243J105)	150.0K	QoQ -62.50% (-250.0K) YoY -72.72% (-400.0K)	All Managers (Combined)	$7.9M	0.7% ($7.9M/$1.2B)	QoQ -64.51% (-$14.4M) YoY -66.65% (-$15.9M)
OnKure Therapeutics, Inc.(OKURcusip68277Q105)	1.8M	QoQ 0.00% (-0) YoY NEW(+1.8M)	All Managers (Combined)	$7.9M	0.6% ($7.9M/$1.2B)	QoQ -49.99% (-$7.9M) YoY NEW(+$7.9M)
Biomea Fusion, Inc.(BMEAcusip09077A106)	3.6M	QoQ 0.00% (-0) YoY 0.00% (-0)	All Managers (Combined)	$7.6M	0.6% ($7.6M/$1.2B)	QoQ -45.10% (-$6.2M) YoY -85.75% (-$45.8M)
Korro Bio, Inc.(KRROcusip500946108)	380.3K	QoQ NEW(+380.3K) YoY -28.13% (-148.9K)	All Managers (Combined)	$6.6M	0.5% ($6.6M/$1.2B)	QoQ NEW(+$6.6M) YoY -86.09% (-$41.0M)
Vaxcyte, Inc.(PCVXcusip92243G108)	175.0K	QoQ -58.82% (-250.0K) YoY -74.45% (-510.0K)	All Managers (Combined)	$6.6M	0.5% ($6.6M/$1.2B)	QoQ -81.00% (-$28.2M) YoY -85.87% (-$40.2M)
(cusip002942100)✕	800.2K	QoQ NEW(+800.2K) YoY NEW(+800.2K)	All Managers (Combined)	$6.0M	0.5% ($6.0M/$1.2B)	QoQ NEW(+$6.0M) YoY NEW(+$6.0M)
MBX Biosciences, Inc.(MBXcusip55287L101)	700.0K	QoQ 0.00% (-0) YoY NEW(+700.0K)	All Managers (Combined)	$5.2M	0.4% ($5.2M/$1.2B)	QoQ -59.95% (-$7.7M) YoY NEW(+$5.2M)
NewAmsterdam Pharma Co N.V.(NAMScusipN62509109)	250.0K	QoQ -92.30% (-3.0M) YoY -83.33% (-1.3M)	All Managers (Combined)	$5.1M	0.4% ($5.1M/$1.2B)	QoQ -93.87% (-$78.4M) YoY -85.57% (-$30.4M)
Enliven Therapeutics, Inc.(ELVNcusip29337E102)	250.0K	QoQ 0.00% (-0) YoY NEW(+250.0K)	All Managers (Combined)	$4.9M	0.4% ($4.9M/$1.2B)	QoQ -12.53% (-$705.0K) YoY NEW(+$4.9M)
Janux Therapeutics, Inc.(JANXcusip47103J105)	150.0K	QoQ -92.85% (-1.9M) YoY -80.00% (-600.0K)	All Managers (Combined)	$4.0M	0.3% ($4.0M/$1.2B)	QoQ -96.39% (-$108.4M) YoY -85.65% (-$24.2M)
PLIANT THERAPEUTICS, INC.(PLRXcusip729139105)	3.0M	QoQ NEW(+3.0M) YoY NEW(+3.0M)	All Managers (Combined)	$4.0M	0.3% ($4.0M/$1.2B)	QoQ NEW(+$4.0M) YoY NEW(+$4.0M)
KALA BIO, Inc.(KALAcusip483119202)	603.0K	QoQ 0.00% (-0) YoY NEW(+603.0K)	All Managers (Combined)	$3.5M	0.3% ($3.5M/$1.2B)	QoQ -17.43% (-$729.7K) YoY NEW(+$3.5M)